AVEO Pharmaceuticals (STU:VPA1) Tax Rate % : 0.00% (As of Sep. 2022)

View and export this data going back to 2013. Start your Free Trial

What is AVEO Pharmaceuticals Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. AVEO Pharmaceuticals's Tax Expense for the three months ended in Sep. 2022 was €0.00 Mil. AVEO Pharmaceuticals's Pre-Tax Income for the three months ended in Sep. 2022 was €-3.30 Mil. Therefore, AVEO Pharmaceuticals's Tax Rate % for the quarter that ended in Sep. 2022 was 0.00%.

AVEO Pharmaceuticals Tax Rate % Historical Data

The historical data trend for AVEO Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVEO Pharmaceuticals Tax Rate % Chart

AVEO Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Tax Rate %

Get a 7-Day Free Trial

-0.15

AVEO Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

AVEO Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

AVEO Pharmaceuticals's Tax Rate % for the fiscal year that ended in Dec. 2021 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2021 )	/	Pre-Tax Income (A: Dec. 2021 )
	=	0	/	-47.208
	=	0.00 %

AVEO Pharmaceuticals's Tax Rate % for the quarter that ended in Sep. 2022 is calculated as

Tax Rate %	=	Tax Expense (Q: Sep. 2022 )	/	Pre-Tax Income (Q: Sep. 2022 )
	=	0	/	-3.299
	=	0.00 %

AVEO Pharmaceuticals Tax Rate % Related Terms

Thank you for viewing the detailed overview of AVEO Pharmaceuticals's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

AVEO Pharmaceuticals (STU:VPA1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AVEO Pharmaceuticals Inc (STU:VPA1) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Winter Street, Boston, MA, USA, 02108

Website

https://www.aveooncology.com

AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth factor receptor, or VEGFR, tyrosine kinase inhibitor, or TKI. The group primarily operates in the U.S.

AVEO Pharmaceuticals (STU:VPA1) Headlines

No Headlines